John LaRocca - 06 Jan 2025 Form 3 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
SVP, General Counsel & Secry
Signature
/s/ John LaRocca
Issuer symbol
YMAB
Transactions as of
06 Jan 2025
Net transactions value
$0
Form type
3
Filing time
16 Jan 2025, 16:44:32 UTC
Previous filing
21 Nov 2022
Next filing
22 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding YMAB Employee Stock Option (right to buy) 06 Jan 2025 Common Stock 142,600 $9.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest and become exercisable as to 25% of the shares subject to the option on January 18, 2025, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Remarks:

Exhibit 24 - Power of Attorney